Yilmazer, GokhanNart, MarufIzmirli, MustafaYavuz, AlpaslanCan, Alper2025-05-102025-05-1020141300-746710.5505/tjoncol.2014.10802-s2.0-84904628191https://doi.org/10.5505/tjoncol.2014.1080https://hdl.handle.net/20.500.14720/10571Can, Alper/0000-0003-4549-5847; Yavuz, Alpaslan/0000-0002-8796-988XOBJECTIVES To assess the survival ratios of patients with brain metastasis after whole brain radiotherapy according to recursive partitioning analysis (RPA) classification and other prognostic factors. METHODS Whole brain radiotherapy results and prognostic factors of 62 patients with brain metastasis were studied retrospectively. RESULTS The median survival rate in our study was 6.9 months. Single variation analysis demonstrated statistically significant survival results independently in female patients, with Karnofsky performance scale value of 70 and over, patients with controlled primary disease, RPA class I, and diagnosed with breast cancer (p<0.05). The results obtained from multi-variation analysis demonstrated statistically significant survival results among female patients, patients with an age of 65 years old and below as well as patients with solitary metastasis and who had undergone surgery (p<0.05). CONCLUSION Prognostic factors of patients must be considered in the treatment of brain metastases by selecting the most suitable process through radiosurgical, surgical resection, and/or whole brain radiotherapy.trinfo:eu-repo/semantics/openAccessBrain MetastasisPrognostic FactorsRpaSurvivalArticle292N/AQ43945WOS:000439267800002